| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |